Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limb Girdle Muscular Dystrophy Type 2D/R3”

2 trials

Showing 2 of 2 results

Early research (Phase 1)Ended earlyNCT06747273
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Efficacy of SRP-9004 Administered by Systemic Infusion in Limb Girdle Muscular Dystrophy Type 2D/R3 Participants in the United States

Who this might be right for
Limb Girdle Muscular DystrophyLimb Girdle Muscular Dystrophy Type 2D/R3
Sarepta Therapeutics, Inc. 4
Not applicableActive Not RecruitingNCT04475926
What this trial is testing

The Natural History of Participants With LGMD2E/R4, LGMD2D/R3, LGMD2C/R5, and LGMD2A/R1 ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice

Who this might be right for
Limb-girdle Muscular Dystrophy
Sarepta Therapeutics, Inc. 205

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation